DSG Capital Advisors’s Merck MRK Stock Holding History

DSG Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$236K	Hold	1,958	–	–	0.04%	118
2025 Q4	$217K	Buy	+1,958	New	+$184K	0.03%	116

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DSG Capital Advisors's MRK Position: Q1 2026 in Review

DSG Capital Advisors held its Merck (MRK) position steady in Q1 2026 at 1,958 shares worth $236K. The position accounts for 0.04% of the portfolio, ranked #118.

DSG Capital Advisors first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

DSG Capital Advisors held 1,958 shares of Merck worth $236K as of Q1 2026.
DSG Capital Advisors left its Merck share count unchanged in Q1 2026.
Merck made up 0.04% of DSG Capital Advisors's portfolio in Q1 2026, its #118 holding.
DSG Capital Advisors first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DSG Capital Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.